Menu Close
Get Involved
Get Involved
Get Involved

Biosimilars are having an increasing role to play in the Canadian health system. How can you stay informed and involved?

  • Provide your comments and questions to Arthritis Consumer Experts at feedback@jointhealth.org 
  • Continue to share perspectives and experiences around this important medication treatment topic
  • Help educate your community – they will be affected by the arrival of biosimilars
  • Understand how biosimilars are assessed and listed on public and private drug plans

Ask your healthcare professional or patient support program about these important questions:

  • What are the experts saying about biosimilars?
  • Will a biosimilar work for me?
  • What is the nocebo effect?
  • What clinical evidence supports the safety and efficacy of switching from a reference biologic to a corresponding biosimilar?
  • What are the biosimilars patient support programs?

Stay Informed

Subscribe to Arthritis Consumer Experts’ JointHealthTM newsletters to keep up with the latest news and background analysis about biosimilars.

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.

Arthritis Consumer Experts
© 2000-2021

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.

Arthritis Consumer Experts
© 2000-2021

ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealthTM information and programs.

This site complies with the HONcode standard for trustworthy health information: verify here.